Celebrate National STEM Day with Miss CEO and Dr. Izumi Hinkson on Saturday, November 7th at 4pm Pacific. Dr. Izumi Hinkson is a Scientific Project Manager in the Therapeutics Insights group at Fluidigm where she manages the delivery of single-cell proteomics research projects, and the development and rollout of innovative products for mass cytometry and imaging mass cytometry. Prior to her role at Fluidigm, Izumi was a Scientific Project Manager at Accelerating Therapeutics for Opportunities in Medicine (ATOM), a public-private consortium for AI-based drug discovery. Izumi is an alumna of the American Association for the Advancement of Science (AAAS) Science & Technology Policy Fellow Program. As a fellow at the National Cancer Institute Center for Biomedical Informatics and Information Technology (CBIIT), she applied her scientific expertise in mass spectrometry-based proteomics to co-lead the development of the NCI Proteomic Data Commons, a cloud-based data and analysis tool sharing platform. Her previous areas of study include proteomics research in prostate cancer, proteostasis, aging and age-related diseases, and rejuvenation. Izumi holds a PhD in Chemical and Systems Biology from Stanford University and a BS in Biochemistry and Molecular Biology from the University of California, Davis.